
© 2024 Der Aktionär
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
22:42 | Sangamo Therapeutics stock soars on Lilly licensing deal | ||
22:06 | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System | Agreement grants Lilly rights to employ Sangamo's novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and... ► Artikel lesen | |
18:30 | DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform | ||
09:43 | Eli Lilly Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
Mi | Primary care firm knownwell joins LillyDirect to offer weight-management services |